Ischemia-modified albumin levels in carbon monoxide poisoning

TÜREDİ S., Cinar O., Kaldirim U., MENTEŞE A., Tatli Ö., Cevik E., ...More

AMERICAN JOURNAL OF EMERGENCY MEDICINE, vol.29, no.6, pp.675-681, 2011 (SCI-Expanded) identifier identifier identifier


Objectives: Ischemia-modified albumin (IMA) is an emerging diagnostic biomarker for many ischemic conditions. This study was conducted to investigate whether there is a change in IMA levels in carbon monoxide (CO) poisoning and, if so, the clinical relevance of IMA levels.